Mitaban label

Mitaban

Mitaban Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

  • Please refer to warning at beginning of the package insert.
  • Not for human use. Keep out of reach of children.
  • MITABAN (amitraz) may be harmful if swallowed by humans. If swallowed, do not induce vomiting (contains xylol) and immediately call a physician. Avoid inhalation of vapors (xylol) and contamination of feed and food stuffs.
  • MITABAN is flammable; when diluted with water, the mixture is not flammable.
  • MITABAN (concentrate or diluted) may cause eye or skin irritation in sensitive persons. Do not get in eyes, on skin or on clothing. If in eyes, wash with water for 15 minutes and call a physician immediately.
  • Protect exposed skin (e.g. with rubber gloves, etc.) when mixing MITABAN with water and treating animals. Wash hands and arms with soap and water after treatment of the pet(s). Dispose of unused MITABAN-water solution by flushing down the drain. Rinse the MITABAN container with water and do not reuse.
  • Avoid handling pets immediately after treatment. Contact may cause skin irritation in sensitive individuals during the first few days after treatment.
  • Amitraz, the active ingredient in MITABAN, has been shown to cause liver tumors in female mice.
  • Ingestion or inhalation may cause central nervous system depression.
  • The Material Safety Data Sheet (MSDS) for Mitaban contains more detailed occupational safety information. To obtain a MSDS please call 1-800-733-5500.
  • To report an adverse reaction please call 1-800-366-5288.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

There is currently no usage information available for this product. We apologize for any inconvenience.

History

There is currently no drug history available for this drug.

Other Information

MITABAN (amitraz) Liquid Concentrate contains 19.9% N’-(2,4 dimethylphenyl)- N-[[(2,4-dimethylphenyl)imino]methyl]-N-methylmethanimidamide (w/w), and also xylol, propylene oxide, and a blend of alkyl benzene sulfonates and exthoxylated polyethers. Amitraz, a diamide, is pale yellow, has a melting point of 86° to 87° C, is not hygroscopic, is stable to heating, soluble in most organic solvents, and sparingly soluble in water.

Mitaban Manufacturers

  • Pharmacia And Upjohn Company
    Mitaban | Pharmacia And Upjohn Company
    No Recall

    Mitaban | Pharmacia And Upjohn Company

    Mitaban | Pharmacia And Upjohn Company

    Long and medium-haired dogs should be clipped closely before treating. Prior to the initial treatment, all dogs should be bathed with a mild soap and water and towel dried. The entire animal should then be topically treated with MITABAN (amitraz) at a rate of 10.6 milliliters (contents of one bottle) per 2 gallons of warm water (250 ppm active drug). Two bottles (21.2 milliliters) per four gallons of water may be necessary to treat large dogs. The entire dog should be thoroughly and completely wetted with the mixture, and then allowed to air dry. Do not rinse or towel dry the dog after treatment with MITABAN. A fresh MITABAN-water mixture should be prepared for each patient; using the same mixture for more than one patient can spread other dermal infections and also the concentration of MITABAN could be reduced to a level which would be less effective than the recommended concentration.

    Three to six topical treatments (14 days apart) are recommended for the treatment of generalized demodicosis. It is important to continue treatment until no viable (alive) mites are found in the skin scrapings at two successive treatments, or until six treatments have been applied. Severe (chronic) cases and dogs which are reinfested may require a second and third series of treatments, and again the treatment should be applied at 14 day intervals. Discontinue treatment of dogs which do not respond clinically.

    When employing MITABAN for treatment of demodicosis, other dogs in the home also should be examined for lesions to ascertain whether treatment of these animals is warranted.

  • Mitaban | Zoetis Inc.
    No Recall

    Mitaban | Zoetis Inc.

    Mitaban | Zoetis Inc.

    Long and medium-haired dogs should be clipped closely before treating. Prior to the initial treatment, all dogs should be bathed with a mild soap and water and towel dried. The entire animal should then be topically treated with MITABAN (amitraz) at a rate of 10.6 milliliters (contents of one bottle) per 2 gallons of warm water (250 ppm active drug). Two bottles (21.2 milliliters) per four gallons of water may be necessary to treat large dogs. The entire dog should be thoroughly and completely wetted with the mixture, and then allowed to air dry. Do not rinse or towel dry the dog after treatment with MITABAN. A fresh MITABAN-water mixture should be prepared for each patient; using the same mixture for more than one patient can spread other dermal infections and also the concentration of MITABAN could be reduced to a level which would be less effective than the recommended concentration.

    Three to six topical treatments (14 days apart) are recommended for the treatment of generalized demodicosis. It is important to continue treatment until no viable (alive) mites are found in the skin scrapings at two successive treatments, or until six treatments have been applied. Severe (chronic) cases and dogs which are reinfested may require a second and third series of treatments, and again the treatment should be applied at 14 day intervals. Discontinue treatment of dogs which do not respond clinically.

    When employing MITABAN for treatment of demodicosis, other dogs in the home also should be examined for lesions to ascertain whether treatment of these animals is warranted.